Showing results (171-180 of 231) with videos related to
Sort By:
Pageof 24
Journal of Breast Cancer|June 15, 2021
Programmed Death Ligand 1 Immunohistochemistry in Triple-Negative Breast Cancer: Evaluation of Inter-Pathologist Concordance and Inter-Assay VariabilitySoomin Ahn, Ji Won Woo, Hyojin Kim, et al.Scientific Reports|April 5, 2020
Streamlined selection of cancer antigens for vaccine development through integrative multi-omics and high-content cell imagingKi-Cheol Han, Daechan Park, Shinyeong Ju, et al.Scientific Reports|January 2, 2025
Prognosis of patients with breast cancer who underwent breast-conserving surgery using a 3D-printed surgical guide after neoadjuvant chemotherapyAh Yoon Kim, Sae Byul Lee, Tae Kyung Yoo, et al.Plos One|July 9, 2014
Toll like receptor 3 & 4 responses of human turbinate derived mesenchymal stem cells: stimulation by double stranded RNA and lipopolysaccharideSe Hwan Hwang, Hye Kyung Cho, Sang Hi Park, et al.Journal of Experimental & Clinical Cancer Research : CR|January 26, 2021
Targeted eicosanoids profiling reveals a prostaglandin reprogramming in breast Cancer by microRNA-155Sinae Kim, Eun Sung Lee, Eun Ji Lee, et al.Journal of Breast Cancer|August 5, 2021
Tumor-Infiltrating Lymphocytes in Human Epidermal Growth Factor Receptor 2-Positive Breast Cancer Receiving Neoadjuvant Docetaxel, Carboplatin, Trastuzumab, and PertuzumabJoo Young Ha, Jeong Eun Kim, Hee Jin Lee, et al.Cancer Letters|December 9, 2014
Bioinformatic and metabolomic analysis reveals miR-155 regulates thiamine level in breast cancerSinae Kim, Je-keun Rhee, Hyun Ju Yoo, et al.Journal of Pathology and Translational Medicine|January 19, 2021
Standardized pathology report for breast cancerSoo Youn Cho, So Yeon Park, Young Kyung Bae, et al.Journal of Nuclear Medicine : Official Publication, Society of Nuclear Medicine|August 14, 2025
Diagnostic Performance of 18F-Fluoroestradiol PET/CT for Axillary Lymph Node Metastasis in Invasive Lobular Carcinoma: A Prospective Feasibility StudyJeongryul Ryu, Sangwon Han, Tae-Kyung Robyn Yoo, et al.Annals of Surgical Oncology|August 24, 2012
ROS1 receptor tyrosine kinase, a druggable target, is frequently overexpressed in non-small cell lung carcinomas via genetic and epigenetic mechanismsHee Jin Lee, Hyang Sook Seol, Joo Young Kim, et al.Pageof 24